2021 Issue №3

Evaluation of the possibility of ultrasound examination of the first metatarsophalangeal joints in the diagnosis of gouty arthritis

Pages

97-103

Abstract

The variety of options for the course of gouty arthritis necessitates the search for informative and accessible methods for diagnosing this disease. The detection of the sodium monourate crystals deposits in synovial fluid is asso­ciated with certain technical difficulties. In this regard, ultrasound diagnos­tics of gout is of particular value. The article raises questions of the im­portance of ultrasound assessment of joints in the diagnosis of gouty arthritis. Especially interesting is the possibility of evaluating the first metatarsoph­alangeal joints as a screening area for research. In our work, we found a high frequency of detection of echographic signs of gout in this area, even in the ab­sence of clinical manifestations. The use of ultrasound examination of the first metatarsophalangeal joints can be recommended at the stage of differential di­agnosis of gouty arthritis in clinical practice of primary specialized care.

Reference

1. Барскова В. Г. Диагностика подагры (лекция) // Научно-практическая ревматология. 2012. Т. 50, № 4. С. 62—66.

2. Елисеев М. С. Классификационные критерии подагры (рекомендации ACR/EULAR) // Научно-практическая ревматология. 2015. Т. 53, № 6. С. 581—585.

3. Мазуров В. И., Петрова М. С., Инамова О. В., Мусейчук М. М. Подагрический артрит — современный взгляд на проблему // Медицинский совет. 2017. № 17. С. 106—112.

4. Никитин А. Д., Никитин Д. В., Никитина Т. В. Возможности современных лучевых методов в диагностике подагрического артрита // Бюллетень меди­цинских интернет-конференций. 2015. Т. 5, № 12. С. 1633.

5. Хитров Н. А. Подагра — королева болезней и болезнь королей (10 запове­дей подагры) // Медицинский совет. 2012. № 3. С. 60—66.

6. Andracco R., Zampogna G., Parodi M., Cimmino M. A. Risk factors for gouty dac­tylitis // Clinical and Experimental Rheumatology. 2009. Vol. 27. P. 993—995.

7. Bhole V., de Vera M., Rahman M. M. et al. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort // Arthritis & Rheumatology. 2010. Vol. 62. P. 1069—1076.

8. Choi H. K., Atkinson K., Karlson E. W. et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men // The New England Journal of Medicine. 2004. Vol. 350. P. 1093—1103.

9. Choi H. K., Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study // BMJ. 2008. Vol. 336. P. 309—312.

10. Choi J. W. J., Ford E. S., Gao X., Choi H. K. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examina­tion Survey // Arthritis & Rheumatology. 2008. Vol. 59. P. 109—116.

11. Kim J. W., Kwak S. G., Lee H. et al. Prevalence and incidence of gout in Korea: data from the national health claims database 2007—2015 // Rheumatology Interna­tional. 2017. Vol. 37. P. 1499—1506.

12. Kuo C. F., Grainge M. J., Mallen C. et al. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study // Annals of the Rheumatic Diseases. 2015. Vol. 74. P. 661—667.

13. Kuo C. F., Grainge M. J., See L. C. et al. Epidemiology and management of gout in Taiwan: a nationwide population study // Arthritis Research and Therapy. 2015. Vol. 17. P. 13.

14. Kutzing M. K., Firestein B. L. Altered uric acid levels and disease states // The Journal of Pharmacology and Experimental Therapeutics. 2008. Vol. 324. P. 1—7.

15. Liu-Bryan R., Terkeltaub R. Evil humors take their toll as innate immunity makes gouty joints TREM-ble // Arthritis & Rheumatology. 2006. Vol. 54, № 2. P. 383—386.

16. Neogi T., Jansen T., Dalbeth N. et al. Gout classification criteria: an American College of Rheumatology: European League Against Rheumatism collaborative initi­ative // Annals of the Rheumatic Diseases. 2015. Vol. 74, № 10. Р. 1789—1798.

17. Richette P., Doherty M., Pascual E. et al. 2016 updated EULAR evidence-based recommendations for the management of gout // Annals of the Rheumatic Diseases. 2017. Vol. 76. P. 29—42.

18. Singh J. A., Gaffo A. Gout epidemiology and comorbidities // Seminars in Ar­thritis and Rheumatism. 2020. № 50. P. 11—16.

19. Singh J. A., Reddy S. G., Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature // Current Opinion in Rheumatology. 2011. Vol. 23. P. 192—202.

20. So A. Developments in the scientific and clinical understanding of gout // Arthritis Research & Therapy. 2008. Vol. 10. P. 221.

21. Swan A., Amer H., Dieppe P. The value of synovial fluid assays in the diagno­sis of joint disease: a literature survey // Annals of the Rheumatic Diseases. 2002. Vol. 61. P. 493—498.

22. Terkeltaub R., Bushinsky D. A., Becker M. A. Recent developments in our under­standing of the renal basis if hyperuricemia and the development of novel antihype­ruricemic therapeutics // Arthritis Research and Therapy. 2006. Vol. 8 (Suppl 1). P. 4.

23. Terslev L., Gutierrez M., Schmidt W. A. et al. OMERACT Ultrasound Working Group: Ultrasound as an outcome measure in gout. a validation process by the OMERACT Ultrasound Working Group // The Journal of Rheumatology. 2015. Vol. 42. P. 2177—2181.

24. Zhu Y., Pandya B. J., Choi H. K. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007—2008 // Arthritis & Rheumatology. 2011. Vol. 63. P. 3136—3141.